We are live on ! Find out more
PSTV

Plus Therapeutics
PSTV

Delisted

PSTV was delisted on the 31st of July, 2026.

Back to rankings

4 hedge funds and large institutions have $5.56M invested in Plus Therapeutics in 2015 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding

Funds holding: 3 → 4 (+1)

4% more capital invested

Capital invested by funds: $5.35M → $5.56M (+$216K)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $12K

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
$12K
Net Calls
-$12K
Net Calls Change
+$4K

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$4.69M
2
PCM
Perkins Capital Management
Minnesota
+$938K

Top Sellers

Rank Fund Capital Flow
1
DC
Davenport & Co
Virginia
-$5.02K
2
EWA
Exencial Wealth Advisors
Oklahoma
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$3.19M +$4.69M +5 +500%
BIT
2
BlackRock Institutional Trust
California
$703K – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$682K – – –
PCM
4
Perkins Capital Management
Minnesota
$325K +$938K +1 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$168K – – –
PCMI
6
Princeton Capital Management Inc
New Jersey
$90K – – –
RAM
7
Redmond Asset Management
Virginia
$37K – – –
UBS Group
8
UBS Group
Switzerland
$34K – – –
Millennium Management
9
Millennium Management
New York
$24K – – –
Northern Trust
10
Northern Trust
Illinois
$24K – – –
Adage Capital Partners
11
Adage Capital Partners
Massachusetts
$23K – – –
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
$23K – – –
Goldman Sachs
13
Goldman Sachs
New York
$21K – – –
Bank of New York Mellon
14
Bank of New York Mellon
New York
$20K – – –
California Public Employees Retirement System
15
California Public Employees Retirement System
California
$18K – – –
CB
16
Commerce Bank
Missouri
$17K – – –
OC
17
Oppenheimer & Co
New York
$15K – – –
Group One Trading
18
Group One Trading
Illinois
$12K – – –
VKH
19
Virtu KCG Holdings
New York
$12K – – –
MCM
20
Marathon Capital Management
Maryland
$10K – – –
NFG
21
Noven Financial Group
Colorado
$10K – – –
New York State Common Retirement Fund
22
New York State Common Retirement Fund
New York
$9K – – –
D.E. Shaw & Co
23
D.E. Shaw & Co
New York
$8K – – –
LPL Financial
24
LPL Financial
California
$8K – – –
BA
25
BlackRock Advisors
Delaware
$7K – – –
1
2

PSTV Hedge Fund Activity: Q4 2015 in Review

4 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q4 2015, worth a combined $5.56M — up 4% from $5.35M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new PSTV positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, adding an estimated $4.69M. The largest seller was Davenport & Co, cutting an estimated $5.02K.

  • 4 institutional investors held Plus Therapeutics (PSTV) as of Q4 2015, up from 3 in Q3 2015.
  • Funds reported $5.56M of Plus Therapeutics stock for Q4 2015, up 4% quarter-over-quarter.
  • 1 fund opened new Plus Therapeutics positions in Q4 2015 and 0 closed out, a net change of +1 holder.
  • The largest Plus Therapeutics buyer in Q4 2015 was Sabby Management, an estimated $4.69M added.
  • The largest Plus Therapeutics seller in Q4 2015 was Davenport & Co, an estimated $5.02K sold.

Based on aggregated 13F filings for Q4 2015.